These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35677295)

  • 21. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
    Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
    Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
    Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.
    Hossain MS; Jaye DL; Pollack BP; Farris AB; Tselanyane ML; David E; Roback JD; Gewirtz AT; Waller EK
    J Immunol; 2011 Nov; 187(10):5130-40. PubMed ID: 22013117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous Graft-Versus-Host Disease of the Gastrointestinal Tract in Patients With Multiple Myeloma and Hematopoietic Stem Cell Transplantation.
    Hammami MB; Talkin R; Al-Taee AM; Schoen MW; Goyal SD; Lai JP
    Gastroenterology Res; 2018 Feb; 11(1):52-57. PubMed ID: 29511407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic stem cells under pressure.
    Ganuza M; McKinney-Freeman S
    Curr Opin Hematol; 2017 Jul; 24(4):314-321. PubMed ID: 28375987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
    Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria.
    Knaus HA; Rottner T; Baumann CK; Cserna J; Mitterbauer M; Schulenburg A; Rabitsch W; Wohlfarth P
    Transplant Cell Ther; 2022 May; 28(5):260.e1-260.e9. PubMed ID: 35217212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
    Zakrzewski JL; Kochman AA; Lu SX; Terwey TH; Kim TD; Hubbard VM; Muriglan SJ; Suh D; Smith OM; Grubin J; Patel N; Chow A; Cabrera-Perez J; Radhakrishnan R; Diab A; Perales MA; Rizzuto G; Menet E; Pamer EG; Heller G; Zúñiga-Pflücker JC; Alpdogan O; van den Brink MR
    Nat Med; 2006 Sep; 12(9):1039-47. PubMed ID: 16936725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.
    D'Aveni M; Notarantonio AB; Bertrand A; Boulangé L; Pochon C; Rubio MT
    Front Immunol; 2020; 11():989. PubMed ID: 32528476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
    Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W
    Front Immunol; 2021; 12():755549. PubMed ID: 34777367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
    Iftikhar R; Chaudhry QUN; Anwer F; Neupane K; Rafae A; Mahmood SK; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Khan M; Ansar I; Ashraf R; Marsh J; Satti TM; Ahmed P
    Blood Rev; 2021 May; 47():100772. PubMed ID: 33187812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide and Antithymocyte Globulin from HLA-Mismatched Related Donors for Nonmalignant Diseases.
    Osumi T; Yoshimura S; Sako M; Uchiyama T; Ishikawa T; Kawai T; Inoue E; Takimoto T; Takeuchi I; Yamada M; Sakamoto K; Yoshida K; Kimura Y; Matsukawa Y; Matsumoto K; Imadome KI; Arai K; Deguchi T; Imai K; Yuza Y; Matsumoto K; Onodera M; Kanegane H; Tomizawa D; Kato M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):e286-e291. PubMed ID: 32798657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of IFN-γ on Pulmonary GVHD after Allo-Hematopoietic Stem Cell Transplantation].
    Xu XL; Chen ZW; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):245-250. PubMed ID: 29397852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.